Clinical efficacy of intermittent androgen suppression treatment of advanced prostate cancer in elderly patients
10.3760/cma.j.issn.0254-9026.2014.09.015
- VernacularTitle:间歇性内分泌治疗老年人晚期前列腺癌的临床疗效分析
- Author:
Chun YANG
;
Jun FENG
;
Jian DONG
;
Deshui YU
;
Jun CONG
- Publication Type:Journal Article
- Keywords:
Prostatic neoplasms;
Hormone replacement therapy
- From:
Chinese Journal of Geriatrics
2014;33(9):980-982
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore clinical effect and safety of intermittent androgen suppression treatment of advanced prostate cancer in elderly patients.Methods 78 patients with advanced prostate cancer were enrolled,and randomly divided into the observation group and the control group (n=39 each).Patients in observation group were treated with intermittent androgen suppression treatment.Patients in control group were treated with persistent androgen suppression treatment.Results The time of therapy was much longer in observation group than in control group (P< 0.001).Quality of life was better in observation group than in control group (P<0.05).The incidences of adverse reactions including anemia,fever and abnormal liver function were lower in observation group than in control group (all P<0.05).Conclusions Intermittent androgen suppression treatment prolongs time to androgen-independent progression,improve the quality of life,reduce drug dosage and the incidence of adverse reactions in the treatment of advanced prostate cancer in the elderly.